Reactogenicity of DTPa-HBV/Hib vaccine administered as a single injection vs DTPa-HBV and Hib vaccines administered simultaneously at separate sites, to infants at 2, 4 and 6 months of age

Author： Omenaca F.   Dal-Re R.   D'Apuzzo V.   Kattamis C.   Gnehm H.P.   Garca-Sicilia J.   Garca-Corbeira P.   for The European DTPa-HBV/Hib 041 Study Group  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.19, Iss.30, 2001-07, pp. : 4260-4266

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered as a single injection, with the DTPa-IPV/Hib and hepatitis B vaccines administered in two simultaneous injections to infants at 2, 4 and 6 months of age

By Aristegui J.   Dal-Re R.   Diez-Delgado J.   Mares J.   Casanovas J.M.   Garcia-Corbeira P.   De Frutos E.   Van Esso D.   Verdaguer J.   De la Flor J.   Moraga F.   Boceta R.   Garcia-Martinez J.A.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3593-3600

Elsevier

Access to resources Recommend Favorite

Assessment of the immunogenicity and reactogenicity of a quadrivalent diphtheria, tetanus, acellular pertussis and hepatitis B (DTPa-HBV) vaccine administered in a single injection with Haemophilus influenzae type b conjugate vaccine, to infants at 2, 4 and 6 months of age

By Aristegui J.   Dal-Re R.   Garrote E.   Gonzalez A.   Arrate J.-P.   Perez A.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 1976-1981

Elsevier

Access to resources Recommend Favorite

The immunogenicity of oral poliomyelitis vaccine in a primary vaccination series at 2, 4 and 6 months given concurrently with Hib, hepatitis B and diphtheria, tetanus and whole-cell pertussis vaccines administered as three separate injections or as a combination pentavalent vaccine

By Hogg K.   Hogg G.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2906-2910

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a recombinant hepatitis B vaccine administered to infants at 2, 4 and 6 months of age

By The Kaiser-UCLA Vaccine Study Group   Greenberg D.P.   Vadheim C.M.   Marcy S.M.   Partridge S.   Jing J.   Chung-Yin C.   Greene T.   Margolis H.S.   Ward J.I.  

Vaccine, Vol. 14, Iss. 8, 1996-06 ,pp. : 811-816

Elsevier

Access to resources Recommend Favorite

Feasibility study of a combined diphtheria-tetanus-acellular pertussis-hepatitis B (DTPa-HBV) vaccine, and comparison of clinical reactions and immune responses with diphtheria-tetanus-acellular pertussis (DTPa) and hepatitis B vaccines applied as mixed or injected into separate limbs

By Usonis V.   Bakasenas V.   Willems P.   Clemens R.  

Vaccine, Vol. 15, Iss. 15, 1997-10 ,pp. : 1680-1686

Elsevier

Access to resources Recommend Favorite